abstract |
3,6-DIIDRO-2-OXO-6H-1,3,4-THADIAZINE DERIVATIVES. The present invention relates to compounds of formula I, wherein R1, R2, Q and B have the meanings indicated according to claim 1, are inhibitors of tyrosine kinases, in particular Met kinase and may be employed, among others, for the treatment of tumors. |